BioSpace News Archive

European Regulatory Committee Recommends Rejecting Puma Biotechnology’s Breast Cancer Medicine

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) offered a negative opinion on Puma Biotechnology’s application for neratinib for breast cancer.

February 23, 2018

·

3 min read

·

Mark Terry

Business

Women in Biotech Underrepresented on Boards of Directors Across the Bay Area

The proverbial glass ceiling for women in biotech has some cracks but it may not yet have shattered – particularly in the Bay Area hotbed.

February 23, 2018

·

2 min read

·

Alex Keown

Shire Under Pressure to Break Up the Business

Drug Development

FDA Gives Shire’s Lanadelumab Priority Review

The U.S. Food and Drug Administration (FDA) has granted Shire’s Biologics License Application (BLA) for lanadelumab (SHP643) priority review.

February 23, 2018

·

2 min read

·

Mark Terry

Business

Teva’s Shrinking U.S. Footprint

Teva Pharmaceuticals will close its offices in Washington, D.C. and New York City as part of the cost-cutting measures.

February 23, 2018

·

3 min read

·

Alex Keown

Policy

Life Science Companies are Litigation Targets for Unhappy Investors

Life science companies are popular targets for securities fraud litigation.

February 23, 2018

·

2 min read

·

Alex Keown

Deals

Tax Reform Could Lead to Spike in Biopharma M&A Activity

The passing of tax reform led most analysts to predict that 2018 will be a strong year for mergers and acquisitions.

February 23, 2018

·

2 min read

·

Mark Terry

Learn some resume action verbs to replace with wea

Career Advice

3 Resume Tweaks to Help Scientists Get a Job in the Private Sector

According to the National Science Foundation (NSF), approximately 42% of life science professionals with doctorate degrees work in academia.

February 23, 2018

·

3 min read

·

Porschia Parker, BioSpace.com Contributor

Encompass Health declares dividend on common stock

Encompass Health Corporation (NYSE: EHC), formerly known as HealthSouth Corporation, today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.25 per share, payable on April 16, 2018, to holders of record on April 2, 2018.

February 23, 2018

·

3 min read

BioCapital

LifeNet Health’s DermACELL® Acellular Dermal Matrix receives Anthem® coverage

Major insurers offering coverage based on milestone clinical trial data demonstrating DermACELL’s superior outcomes

February 23, 2018

·

2 min read

FDA

Mallinckrodt Receives FDA Acceptance of Stannsoporfin New Drug Application Filing

If approved, the drug is expected to become the first and only pharmacologic option in the U.S. indicated for treatment of neonates at risk for developing severe hyperbilirubinemia, or severe jaundice.

February 23, 2018

·

4 min read